Literature DB >> 10852239

LPS-induced neuroinflammatory effects do not recover with time.

B Hauss-Wegrzyniak1, P D Vraniak, G L Wenk.   

Abstract

Inflammatory processes develop in the vicinity of the neuropathological hallmarks associated with Alzheimer's disease (AD) and may play a role in the progression of the disease and its clinical expression. We have previously reported that chronic infusion of LPS into the fourth ventricle of rat brains reproduced many of the inflammatory and pathological changes seen in the brain of AD patients. In the current study, we used the same animal model to investigate the effects of longer infusion of LPS and whether these effects could recover over time. The results show that doubling the time of LPS infusion did not increase the inflammatory reaction and did not produce a significantly greater behavioral impairment. Waiting for 37 days after the cessation of the LPS infusion did not decrease the density of activated microglia and did not improve performances in the Morris water maze task. The results suggest that inflammation may contribute to the pathogenic mechanisms that underlie the clinical expression of AD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852239     DOI: 10.1097/00001756-200006050-00032

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  33 in total

1.  Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-α in the retina.

Authors:  Shahid Husain; Gregory I Liou; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-20       Impact factor: 4.799

2.  Metabolic and behavioral deficits following a routine surgical procedure in rats.

Authors:  David B Frumberg; Marion S Fernando; Dianne E Lee; Anat Biegon; Wynne K Schiffer
Journal:  Brain Res       Date:  2007-02-08       Impact factor: 3.252

Review 3.  Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.

Authors:  David H Cribbs
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-04       Impact factor: 4.388

4.  Differential sensitivity to endotoxin exposure in young and middle-age mice.

Authors:  Rachel A Kohman; Beth Crowell; Alexander W Kusnecov
Journal:  Brain Behav Immun       Date:  2009-12-16       Impact factor: 7.217

5.  Behavioral, structural and molecular changes following long-term hippocampal IL-1β overexpression in transgenic mice.

Authors:  Amy M Hein; Troy J Zarcone; David B Parfitt; Sarah B Matousek; Dena M Carbonari; John A Olschowka; M Kerry O'Banion
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-12       Impact factor: 4.147

6.  Structural brain changes and all-cause mortality in the elderly population-the mediating role of inflammation.

Authors:  Uta Hanning; Andreas Roesler; Annette Peters; Klaus Berger; Bernhard T Baune
Journal:  Age (Dordr)       Date:  2016-10-20

7.  NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits.

Authors:  Marc Weberpals; Michael Hermes; S Hermann; Markus P Kummer; Dick Terwel; Alexander Semmler; Meike Berger; Michael Schäfers; Michael T Heneka
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

8.  NSAIDs may protect against age-related brain atrophy.

Authors:  Barbara B Bendlin; Lisa M Newman; Michele L Ries; Luigi Puglielli; Cynthia M Carlsson; Mark A Sager; Howard A Rowley; Catherine L Gallagher; Auriel A Willette; Andrew L Alexander; Sanjay Asthana; Sterling C Johnson
Journal:  Front Aging Neurosci       Date:  2010-09-03       Impact factor: 5.750

Review 9.  Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction.

Authors:  Diana M Sama; Christopher M Norris
Journal:  Ageing Res Rev       Date:  2013-06-08       Impact factor: 10.895

10.  Inflammation as a potential mediator for the association between periodontal disease and Alzheimer's disease.

Authors:  Amber Watts; Eileen M Crimmins; Margaret Gatz
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.